Butter C
Abt. Kardiologie, Herzzentrum Brandenburg in Bernau, Deutschland.
Herz. 2011 Oct;36(7):577-85. doi: 10.1007/s00059-011-3506-8.
Cardiac resynchronisation therapy (CRT) has opened up new perspectives over the past 10 years for highly symptomatic patients with severe systolic heart failure. The present article analyses and comments on recent publications which have lead to an expansion of the indication to patients with mild symptoms of heart failure, and which resulted in the modification of current European guidelines in 2010. The data available from narrow QRS complex studies are critically examined. Furthermore, the latest technical innovations in the field of CRT, which have helped to ease the implantation procedure and achieve higher success rates, are presented. Finally, new wireless ultrasound technology to stimulate the left ventricle, currently in an early clinical phase of evaluation, is presented as a potential alternative in the future.
在过去十年中，心脏再同步治疗（CRT）为重度收缩性心力衰竭的高度症状性患者开辟了新的前景。本文分析并评论了近期的出版物，这些出版物导致心力衰竭轻度症状患者的适应症扩大，并促成了2010年欧洲现行指南的修订。对窄QRS波群研究中可得的数据进行了批判性审查。此外，还介绍了CRT领域的最新技术创新，这些创新有助于简化植入程序并提高成功率。最后，目前处于早期临床评估阶段的用于刺激左心室的新型无线超声技术作为未来一种潜在的替代方案被提出。
